![[(5-Nitro-1H-benzimidazol-2-yl)thio]acetic acid - chemical structure image](https://media.scbt.com/product/5-nitro-1h-benzimidazol-2-yl-thioacetic-acid-structure_23_42_b_234214.jpg)
![[(5-Nitro-1H-benzimidazol-2-yl)thio]acetic acid - chemical structure image](https://media.scbt.com/product/5-nitro-1h-benzimidazol-2-yl-thioacetic-acid-structure_23_42_t_234214.jpg "Molecular structure of [(5-Nitro-1H-benzimidazol-2-yl)thio]acetic acid")
Molecular structure of [(5-Nitro-1H-benzimidazol-2-yl)thio]acetic acid
[(5-Nitro-1H-benzimidazol-2-yl)thio]acetic acid
Molecular Weight:
253.23
Molecular Formula:
C9H7N3O4S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Safety Information
SDS & Certificate of Analysis
Zanamivir sesquihydrate inhibits the activity of neuraminidase enzymes, which are necessary for the release of new viral particles from infected cells. By binding to the active site of neuraminidase, it prevents the cleavage of sialic acid residues on the surface of host cells and viral particles. This inhibition blocks the release of new viral particles from infected cells, thereby reducing the spread of the virus within the host. Zanamivir sesquihydrate′s mechanism of action involves disrupting the enzymatic activity of neuraminidase, thereby interfering with the replication and spread of certain viruses.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
[(5-Nitro-1H-benzimidazol-2-yl)thio]acetic acid, 500 mg | sc-318948 | 500 mg | $270.00 |